연구

  1. Home
  2. 연구

임상연구지원 (CIDR)

임상연구지원 (CIDR)

심장혈관질환 분야의 연구 의욕을 고취시키기 위해, 새로운 치료법을 모색하는 연구계획서를 제출한 연구자들을 선정하여 각종 지원을 하고 있습니다.

Research Activity

  1. IRIS-FFR A Multicenter, prospective cohort to evaluate the natural history of FFR guided Percutaneous Coronary Intervention
    📑ClinicalTrials.gov : NCT01366404
  2. IRIS-FFR-TANDEM A Multicenter, prospective cohort to evaluate the effect of FFR guided Percutaneous Coronary Intervention in coronary tandem lesions
    📑ClinicalTrials.gov : NCT02797561

  1. FATE-MAIN Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease
    📑ClinicalTrials.gov : NCT05829889
  2. IRIS-MAIN A GLOBAL, MULTICENTER, PROSPECTIVE, REAL WORLD OBSERVATIONAL STUDY FOR LEFT MAIN DISEASE TREATMENT
    📑ClinicalTrials.gov : NCT01341327
  3. MAIN COMPARE Ten-Year Outcomes of Stents Versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
    📑ClinicalTrials.gov : NCT02791412
  4. PRE-COMBAT I Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease
    📑ClinicalTrials.gov : NCT00422968
  5. PRE-COMBAT II Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis
    📑ClinicalTrials.gov : NCT01348022

  1. OCTIVUS Optical Coherence Tomography versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention
    📑ClinicalTrials.gov : NCT03394079
  2. IRIS Imaging registry Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02792075
  3. PREVENT Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque
    📑ClinicalTrials.gov : NCT02316886
  4. POST-PCI Pragmatic Trial Comparing Symptom-Oriented Versus Routine Stress Testing in High-Risk Patients Undergoing Percutaneous Coronary Intervention
    📑ClinicalTrials.gov : NCT03217877

  1. IRIS BioFreedom Evaluation of Effectiveness and Safety of BIOFREEDOM™ FAMILY Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT03190057
  2. IRIS-BIOMATRIX Evaluation of Effectiveness and Safety of BIOMATRIX in Routine Clinical Practice; A multicenter, PROSPECTIVE OBSERVATIONAL STUDY
    📑ClinicalTrials.gov : NCT01350778
  3. IRIS-Cilotax Evaluation of effectiveness and safety of DXR Stent in Routine Clinical Practice; A multicenter prospective observational cohort study
    📑ClinicalTrials.gov : NCT01612819
  4. IRIS-DEB Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study
    📑ClinicalTrials.gov : NCT02038660
  5. IRIS DESyne X2 Evaluation of Effectiveness and Safety of DESyne X2 in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT03588481
  6. IRIS-ELEMENT Evaluation of Effectiveness and Safety of PROMUS ELEMENT Stents in Routine Clinical Practice
    📑ClinicalTrials.gov : NCT01350791
  7. IRIS-GENOUS STEMI Evaluation of Effectiveness and Safety of the GENOUS STENT in ST-Segment Elevation Myocardial Infarction
    📑ClinicalTrials.gov : NCT01348373
  8. IRIS-INTEGRITY Evaluation of Effectiveness and Safety of Resolute Integrity DES in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study
    📑ClinicalTrials.gov : NCT01392846
  9. IRIS-NOBORI Evaluation of Effectiveness and Safety of NOBORI stent in Routine Clinical Practice; A multicenter, PROSPECTIVE OBSERVATIONAL STUDY
    📑ClinicalTrials.gov : NCT01348360
  10. IRIS-ONYX Evaluation of Effectiveness and Safety of Resolute Onyx™ and Onyx Frontier™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02593994
  11. IRIS-Orsiro Evaluation of Effectiveness and Safety of Orsiro™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02039739
  12. IRIS Skypoint a Non-randomized, Prospective, Open-label Registry to Compare the Effectiveness and Safety of XIENCE Skypoint™ Stents Versus Other DESs in Patients With Coronary Artery Disease
    📑ClinicalTrials.gov : NCT05981911
  13. IRIS-Premier Evaluation of Effectiveness and Safety of Promus PREMIER in Routine Clinical Practice; A Multicenter, Phase-IV, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02060968
  14. IRIS-PRIME Evaluation of Effectiveness and Safety of XIENCE PRIME™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT01348399
  15. IRIS-ROTA Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT03427996
  16. IRIS Sierra Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
    📑ClinicalTrials.gov : NCT03967158
  17. IRIS-Tansei Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT04443530
  18. IRIS-SYNERGY Evaluation of Effectiveness and Safety of Synergy™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02720419
  19. IRIS Synergy XD And Megatron Evaluation of Effectiveness and Safety of Synergy™ XD Stent and Synergy Megatron™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT05044273
  20. IRIS Coroflex ISAR NEO registry Evaluation of Effectiveness and Safety of Coroflex ISAR NEO Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT06177743
  21. IRIS-ULTIMASTER Evaluation of Effectiveness and Safety of Ultimaster® Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
    📑ClinicalTrials.gov : NCT02719106
  22. IRIS-Xpedition/Alpine/Sierra Evaluation of Effectiveness and Safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
    📑ClinicalTrials.gov : NCT02042300
  23. K-XIENCE Evaluation of Effectiveness and Safety of Everolimus-Eluting Stents in Routine Clinical Practice
    📑ClinicalTrials.gov : NCT01350869
  24. DESSIAN Evaluation of Diabetic Effects on Clinical Outcomes After Sirolimus-Eluting Stents in the AsIAN Population
    📑ClinicalTrials.gov : NCT00997711

  1. DEFINE-DM Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
    📑ClinicalTrials.gov : NCT05831085
  2. Asan-MV Registry Asan Multivessel Registry
    📑ClinicalTrials.gov : NCT02039752
  3. BEST Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease
    📑ClinicalTrials.gov : NCT00997828

  1. IRIS-CTO Registry Chronic Total Occlusion Registry
    📑ClinicalTrials.gov : NCT04041921
  2. DECISION-CTO Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion
    📑ClinicalTrials.gov : NCT01078051

  1. ASAN-MI Registry Asan Medical Center Myocardial Infarction Registry
    📑ClinicalTrials.gov : NCT03412435

  1. TAILORED-CHIP TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI
    📑ClinicalTrials.gov : NCT03465644
  2. EPIC-CAD Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease
    📑ClinicalTrials.gov : NCT03718559
  3. RENOVATE Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
    📑ClinicalTrials.gov : NCT04258488
  4. PROTECT-HBR Potassium-Competitive Acid Blocker versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
    📑ClinicalTrials.gov : NCT04416581
  5. TICAKOREA Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
    📑ClinicalTrials.gov : NCT02094963
  6. OPTIMA Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
    📑ClinicalTrials.gov : NCT02319941
  7. FIMA-DEFER Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease
    📑ClinicalTrials.gov : NCT01384747
  8. PRIDE Effectiveness of Clopidogrel Resinate in PCI
    📑ClinicalTrials.gov : NCT01349777
  9. STABLE Statin and Atheroma Vulnerability Evaluation
    📑ClinicalTrials.gov : NCT00997880
  10. DES-LATE Optimal Duration of Clopidogrel Therapy after Drug-Eluting Stent Implantation to Reduce Late Coronary Arterial Thrombotic Events
    📑ClinicalTrials.gov : NCT01186146

  1. Variant ICD Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
    📑ClinicalTrials.gov : NCT02845531

  1. ENAVO-TAVR ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
    📑ClinicalTrials.gov : NCT05672836
  2. ASAN-AVR Registry ASAN Medical Center Aortic Valve Replacement Registry
    📑ClinicalTrials.gov : NCT03298178
  3. SENTINEL pilot Registry The Sentinel Registry
    📑ClinicalTrials.gov : NCT05217888
  4. Asian TAVR Registry The Asian Transcatheter Aortic Valve Replacement Registry
    📑ClinicalTrials.gov : NCT02308150
  5. ADAPT-TAVR Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement
    📑ClinicalTrials.gov : NCT03284827

  1. HOWTO-BRS Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement
    📑ClinicalTrials.gov : NCT03175523
  2. BVS Late Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events
    📑ClinicalTrials.gov : NCT02939872
  3. IRIS-BVS Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice
    📑ClinicalTrials.gov : NCT02622100